This inventor holds 1 USPTO granted patent and 8 published patent applications and 2 EPO patents. Top assignees: Km Biologics Co., Ltd., Kyoto University. Active years: 2023.
Company Filing History:
1 out of 24 
1 out of 859 
Years Active: 2023
Title: Koichiro Hata: Innovator in Liver Damage Diagnostics
Introduction
Koichiro Hata is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of medical diagnostics, particularly concerning liver health. His innovative work has led to advancements in the understanding and treatment of liver-related conditions.
Latest Patents
Hata holds a patent for a diagnostic agent and medicine that comprises ADAMTS13 as its main ingredient. This patent introduces a new use of ADAMTS13 in the clinical field. It provides methods for monitoring the onset of liver damage, hepatic ischemia/reperfusion injury, and liver function after transplantation. The methods involve measuring or monitoring ADAMTS13 activity in samples from mammals. Additionally, the patent includes an agent for treating diseases such as liver damage and hepatic dysfunction after liver transplantation, which utilizes ADAMTS13 or its mutants as effective ingredients. He has 1 patent to his name.
Career Highlights
Throughout his career, Koichiro Hata has worked with prominent organizations, including Km Biologics Co., Ltd. and Kyoto University. His research has focused on the clinical applications of ADAMTS13, contributing to the advancement of medical diagnostics and treatment options.
Collaborations
Hata has collaborated with esteemed colleagues, including Toyonari Kubota and Shinji Uemoto. Their joint efforts have furthered research in the field of liver health and diagnostics.
Conclusion
Koichiro Hata's innovative work in the field of liver diagnostics showcases the importance of research and development in medicine. His contributions have the potential to improve patient outcomes and enhance the understanding of liver-related diseases.